
|Videos|May 26, 2016
- Gastrointestinal Cancers: mCRC (Issue 8)
Novel Targets in Gastric Cancer
Author(s)Manish Shah, MD
Manish A. Shah, MD, medical oncology, NewYork-Presbyterian/Weill Cornell discusses novel targets in gastric cancer outside of HER2.
Advertisement
Articles in this issue
over 9 years ago
Pessimism Surrounds VEGF Inhibitors in Advanced Gastric Cancerover 9 years ago
The Link Between Helicobacter Pylori and Gastric Cancerover 9 years ago
Unmet Needs and Future Treatment Approaches in Gastric CancerAdvertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
3
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
4
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
5







































